Viewing Study NCT03936933


Ignite Creation Date: 2025-12-25 @ 2:44 AM
Ignite Modification Date: 2026-01-07 @ 9:01 AM
Study NCT ID: NCT03936933
Status: TERMINATED
Last Update Posted: 2025-02-17
First Post: 2019-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer
Sponsor: Eurofarma Laboratorios S.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module